Science & Technology
Science and Technology
Science and Technology
Mon, January 5, 2009
Fri, January 2, 2009
Wed, December 31, 2008
JMAR Reveals Significant Purity Differences among Leading Brands of Bottled Water
SAN DIEGO--([ BUSINESS WIRE ])--JMAR Technologies, Inc. (OTCBB: JMAR), a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive materials, today announced the results of an independent study into the different purity levels of the leading brands of bottled water based on the Company's unique pathogen detection technology. The findings were surprising as they revealed that many of the higher priced brands contained heavier concentrations of bio-particle contamination than less expensive brands. The results of the study can be viewed at [ http://www.jmar.com/BioSentry_bottled_water.shtml ].
These results indicate that, in addition to protecting water supplies against contamination, the Company's BioSentry® detection systems can now be used in the marketplace to protect consumers. Accordingly, the Company expects to focus its initial marketing efforts for BioSentry® towards the beverage, pharmaceutical, food processing and healthcare markets. It is expected that these four industries will likely accept BioSentry® as the industry standard in successfully detecting bacteria during manufacturing processes.
"This practical application of our BioSentry® technology in evaluating the purity of bottled water demonstrates a mature product ready to provide consumers with the security of knowing that their drinking water is safe from dangerous levels of harmful pathogens," said JMAR's CEO, C. Neil Beer, Ph.D. "We are looking forward to launching a nationwide media campaign to report these findings as well as further strengthen JMAR's position as a bio-detection company with innovative and essential products."
The nationwide media campaign will launch in January 2009 and is designed to build awareness for JMAR's award-winning, EPA tested laser-based BioSentry® system, the only commercialized online system for real-time detection of bacteria in water. BioSentry® is currently providing water quality security at sites in the U.S., Europe, and other locations worldwide. The campaign will target major media outlets across the nation, including broadcast, print and Internet.
To be added to JMAR Technologies' investor lists, please contact Haris Tajyar at [ htajyar@irintl.com ] or 818-382-9702.
About JMAR
JMAR Technologies, Inc. (OTCBB: JMAR) is a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials. Coupled with its established expertise in building advanced laser systems, JMAR provides solutions for a broad range of military, industrial and commercial applications. The Company draws on more than twenty years of experience and twenty-nine patents and patents pending in photonics, laser and detection technologies to develop products and solutions that address some of the world's most pressing issues such as water quality, hazard detection and homeland security. JMAR's vision is to continue to develop innovative technologies and products that support the advancement of global health, safety, and security initiatives. For further information on JMAR Technologies, please visit [ www.jmar.com ].
Forward Looking Statements: This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the uncertainty of acceptance in the market for our products and technologies or the acceptance of our customers' products or technologies which incorporate our products and technologies, the failure of our technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets, cost and margins for JMAR's products, current or future government regulations affecting the use of JMAR's products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company's Form 10-K for the year ended December 31, 2007 filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.
